Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aju Mathew

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
The Breast Journal|August 29, 2017
Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancerAju Mathew, Tala Achkar, Shira Abberbock, et al.
BMC Cancer|September 1, 2017
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapyTalal Hilal, Mary Nakazawa, Jacob Hodskins, et al.
JCO Global Oncology|April 11, 2022
Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in IndiaAju Mathew, Serena Joseph, Jeffrey Boby, et al.
Familial Cancer|November 15, 2024
BRCAIndica: a resource for ACMG/AMP classified BRCA1 and BRCA2 variantsAastha Vatsyayan, R I Anu, Prerika Mathur, et al.
JCO Global Oncology|July 19, 2022
Cancer Medicines: What Is Essential and Affordable in India?Manju Sengar, Adam Fundytus, Wilma Hopman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Combined Blockade of Activating <i>ERBB2</i> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerSarah Croessmann, Luigi Formisano, Lisa N Kinch, et al.
JCO Global Oncology|March 14, 2024
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in IndiaAju Mathew, Sissmol Davis, Jeffrey Mathew Boby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsPeilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Journal of the National Cancer Institute|July 3, 2018
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable TargetsDamir Varešlija, Nolan Priedigkeit, Ailís Fagan, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The Breast Journal|August 29, 2017
Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancerAju Mathew, Tala Achkar, Shira Abberbock, et al.
BMC Cancer|September 1, 2017
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapyTalal Hilal, Mary Nakazawa, Jacob Hodskins, et al.
JCO Global Oncology|April 11, 2022
Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in IndiaAju Mathew, Serena Joseph, Jeffrey Boby, et al.
Familial Cancer|November 15, 2024
BRCAIndica: a resource for ACMG/AMP classified BRCA1 and BRCA2 variantsAastha Vatsyayan, R I Anu, Prerika Mathur, et al.
JCO Global Oncology|July 19, 2022
Cancer Medicines: What Is Essential and Affordable in India?Manju Sengar, Adam Fundytus, Wilma Hopman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Combined Blockade of Activating <i>ERBB2</i> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast CancerSarah Croessmann, Luigi Formisano, Lisa N Kinch, et al.
JCO Global Oncology|March 14, 2024
Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in IndiaAju Mathew, Sissmol Davis, Jeffrey Mathew Boby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer PatientsPeilu Wang, Amir Bahreini, Rekha Gyanchandani, et al.
Journal of the National Cancer Institute|July 3, 2018
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable TargetsDamir Varešlija, Nolan Priedigkeit, Ailís Fagan, et al.
Pageof 7